Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study

被引:0
作者
R. M. Bruno
A. Salvati
M. Barzacchi
K. Raimo
S. Taddei
L. Ghiadoni
A. Solini
机构
[1] Institute of Clinical Physiology – CNR,Department of Clinical and Experimental Medicine
[2] University of Pisa,undefined
来源
Cardiovascular Diabetology | / 14卷
关键词
Renal resistive index; Hypertension; Type 2 diabetes; Arterial stiffness; Renal outcome; Prospective study; Microalbuminuria;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 197 条
  • [1] Jha V(2013)Chronic kidney disease: global dimension and perspectives Lancet 382 260-72
  • [2] Garcia-Garcia G(2012)Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Lancet 380 1662-73
  • [3] Iseki K(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-81
  • [4] Li Z(2011)Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 1341-52
  • [5] Naicker S(2014)Markers of and risk factors for the development and progression of diabetic kidney disease Am J Kidney Dis 63 S39-62
  • [6] Plattner B(2006)Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur Heart J 27 2588-605
  • [7] Fox CS(2008)Endothelial function assessment in complicated hypertension Curr Pharm Des 14 1761-70
  • [8] Matsushita K(2009)Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension Curr Hypertens Rep 11 190-6
  • [9] Woodward M(2014)Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients Cardiovasc Diabetol 13 128-5
  • [10] Bilo HJ(2013)Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes Cardiovasc Diabetol 12 41-53